ExodusPoint Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$267K Buy
+52,993
New +$267K ﹤0.01% 1198
2025
Q1
Sell
-246,833
Closed -$1.81M 1911
2024
Q4
$1.81M Buy
+246,833
New +$1.81M 0.01% 687
2024
Q2
Sell
-33,607
Closed -$340K 1867
2024
Q1
$340K Sell
33,607
-104,619
-76% -$1.06M ﹤0.01% 1109
2023
Q4
$1.39M Buy
138,226
+57,132
+70% +$575K 0.01% 639
2023
Q3
$760K Buy
81,094
+62,720
+341% +$588K 0.01% 1025
2023
Q2
$451K Sell
18,374
-20,518
-53% -$504K ﹤0.01% 1306
2023
Q1
$905K Buy
38,892
+14,767
+61% +$344K 0.01% 1079
2022
Q4
$611K Sell
24,125
-15,243
-39% -$386K 0.01% 1075
2022
Q3
$759K Sell
39,368
-5,600
-12% -$108K 0.01% 1188
2022
Q2
$1.15M Sell
44,968
-12,359
-22% -$315K 0.01% 976
2022
Q1
$1.47M Buy
+57,327
New +$1.47M 0.02% 877
2021
Q2
Sell
-18,790
Closed -$963K 2757
2021
Q1
$963K Buy
+18,790
New +$963K 0.01% 896